FDA approves 2nd gene therapy for blood cancer, this one for aggressive lymphoma in adults – Chicago Tribune
Chicago Tribune |
FDA approves 2nd gene therapy for blood cancer, this one for aggressive lymphoma in adults
Chicago Tribune U.S. regulators on Wednesday approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive lymphoma in adults. The Food and Drug Administration allowed sales of the treatment from Kite Pharma. It uses the same … FDA Approves Another Amazing And Costly Cancer-Killing Gene Therapy US Regulators Approve 2nd Gene Therapy for Blood Cancer US FDA approves Gilead cancer gene therapy; price set at $373000 |
